1 Insulin Like Growth Factor I Market Overview 1.1 Product Overview and Scope of Insulin Like Growth Factor I 1.2 Insulin Like Growth Factor I Segment by Type 1.2.1 Global Insulin Like Growth Factor I Sales Growth Rate Comparison by Type (2021-2027) 1.2.2 CIGB-845 1.2.3 Dusigitumab 1.2.4 GM-6 1.2.5 M-610.27 1.2.6 M-630 1.2.7 Others 1.3 Insulin Like Growth Factor I Segment by Application 1.3.1 Insulin Like Growth Factor I Sales Comparison by Application: (2021-2027) 1.3.2 Alzheimer's Disease 1.3.3 Breast Cancer 1.3.4 Huntington Disease 1.3.5 Muscular Dystrophy 1.3.6 Others 1.4 Global Insulin Like Growth Factor I Market Size Estimates and Forecasts 1.4.1 Global Insulin Like Growth Factor I Revenue 2016-2027 1.4.2 Global Insulin Like Growth Factor I Sales 2016-2027 1.4.3 Insulin Like Growth Factor I Market Size by Region: 2016 Versus 2021 Versus 2027 2 Insulin Like Growth Factor I Market Competition by Manufacturers 2.1 Global Insulin Like Growth Factor I Sales Market Share by Manufacturers (2016-2021) 2.2 Global Insulin Like Growth Factor I Revenue Market Share by Manufacturers (2016-2021) 2.3 Global Insulin Like Growth Factor I Average Price by Manufacturers (2016-2021) 2.4 Manufacturers Insulin Like Growth Factor I Manufacturing Sites, Area Served, Product Type 2.5 Insulin Like Growth Factor I Market Competitive Situation and Trends 2.5.1 Insulin Like Growth Factor I Market Concentration Rate 2.5.2 The Global Top 5 and Top 10 Largest Insulin Like Growth Factor I Players Market Share by Revenue 2.5.3 Global Insulin Like Growth Factor I Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans 3 Insulin Like Growth Factor I Retrospective Market Scenario by Region 3.1 Global Insulin Like Growth Factor I Retrospective Market Scenario in Revenue by Region: 2016-2021 3.2 Global Insulin Like Growth Factor I Retrospective Market Scenario in Sales by Region: 2016-2021 3.3 North America Insulin Like Growth Factor I Market Facts & Figures by Country 3.3.1 North America Insulin Like Growth Factor I Sales by Country 3.3.2 North America Insulin Like Growth Factor I Revenue by Country 3.3.3 U.S. 3.3.4 Canada 3.4 Europe Insulin Like Growth Factor I Market Facts & Figures by Country 3.4.1 Europe Insulin Like Growth Factor I Sales by Country 3.4.2 Europe Insulin Like Growth Factor I Revenue by Country 3.4.3 Germany 3.4.4 France 3.4.5 U.K. 3.4.6 Italy 3.4.7 Russia 3.5 Asia Pacific Insulin Like Growth Factor I Market Facts & Figures by Region 3.5.1 Asia Pacific Insulin Like Growth Factor I Sales by Region 3.5.2 Asia Pacific Insulin Like Growth Factor I Revenue by Region 3.5.3 China 3.5.4 Japan 3.5.5 South Korea 3.5.6 India 3.5.7 Australia 3.5.8 Taiwan 3.5.9 Indonesia 3.5.10 Thailand 3.5.11 Malaysia 3.5.12 Philippines 3.5.13 Vietnam 3.6 Latin America Insulin Like Growth Factor I Market Facts & Figures by Country 3.6.1 Latin America Insulin Like Growth Factor I Sales by Country 3.6.2 Latin America Insulin Like Growth Factor I Revenue by Country 3.6.3 Mexico 3.6.4 Brazil 3.6.5 Argentina 3.7 Middle East and Africa Insulin Like Growth Factor I Market Facts & Figures by Country 3.7.1 Middle East and Africa Insulin Like Growth Factor I Sales by Country 3.7.2 Middle East and Africa Insulin Like Growth Factor I Revenue by Country 3.7.3 Turkey 3.7.4 Saudi Arabia 3.7.5 U.A.E 4 Global Insulin Like Growth Factor I Historic Market Analysis by Type 4.1 Global Insulin Like Growth Factor I Sales Market Share by Type (2016-2021) 4.2 Global Insulin Like Growth Factor I Revenue Market Share by Type (2016-2021) 4.3 Global Insulin Like Growth Factor I Price by Type (2016-2021) 5 Global Insulin Like Growth Factor I Historic Market Analysis by Application 5.1 Global Insulin Like Growth Factor I Sales Market Share by Application (2016-2021) 5.2 Global Insulin Like Growth Factor I Revenue Market Share by Application (2016-2021) 5.3 Global Insulin Like Growth Factor I Price by Application (2016-2021) 6 Key Companies Profiled 6.1 Boehringer Ingelheim GmbH 6.1.1 Boehringer Ingelheim GmbH Corporation Information 6.1.2 Boehringer Ingelheim GmbH Description and Business Overview 6.1.3 Boehringer Ingelheim GmbH Insulin Like Growth Factor I Sales, Revenue and Gross Margin (2016-2021) 6.1.4 Boehringer Ingelheim GmbH Product Portfolio 6.1.5 Boehringer Ingelheim GmbH Recent Developments/Updates 6.2 Genervon Biopharmaceuticals LLC 6.2.1 Genervon Biopharmaceuticals LLC Corporation Information 6.2.2 Genervon Biopharmaceuticals LLC Description and Business Overview 6.2.3 Genervon Biopharmaceuticals LLC Insulin Like Growth Factor I Sales, Revenue and Gross Margin (2016-2021) 6.2.4 Genervon Biopharmaceuticals LLC Product Portfolio 6.2.5 Genervon Biopharmaceuticals LLC Recent Developments/Updates 6.3 MedImmune LLC 6.3.1 MedImmune LLC Corporation Information 6.3.2 MedImmune LLC Description and Business Overview 6.3.3 MedImmune LLC Insulin Like Growth Factor I Sales, Revenue and Gross Margin (2016-2021) 6.3.4 MedImmune LLC Product Portfolio 6.3.5 MedImmune LLC Recent Developments/Updates 6.4 Regulaxis SAS 6.4.1 Regulaxis SAS Corporation Information 6.4.2 Regulaxis SAS Description and Business Overview 6.4.3 Regulaxis SAS Insulin Like Growth Factor I Sales, Revenue and Gross Margin (2016-2021) 6.4.4 Regulaxis SAS Product Portfolio 6.4.5 Regulaxis SAS Recent Developments/Updates 7 Insulin Like Growth Factor I Manufacturing Cost Analysis 7.1 Insulin Like Growth Factor I Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Key Suppliers of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.3 Manufacturing Process Analysis of Insulin Like Growth Factor I 7.4 Insulin Like Growth Factor I Industrial Chain Analysis 8 Marketing Channel, Distributors and Customers 8.1 Marketing Channel 8.2 Insulin Like Growth Factor I Distributors List 8.3 Insulin Like Growth Factor I Customers 9 Insulin Like Growth Factor I Market Dynamics 9.1 Insulin Like Growth Factor I Industry Trends 9.2 Insulin Like Growth Factor I Growth Drivers 9.3 Insulin Like Growth Factor I Market Challenges 9.4 Insulin Like Growth Factor I Market Restraints 10 Global Market Forecast 10.1 Insulin Like Growth Factor I Market Estimates and Projections by Type 10.1.1 Global Forecasted Sales of Insulin Like Growth Factor I by Type (2022-2027) 10.1.2 Global Forecasted Revenue of Insulin Like Growth Factor I by Type (2022-2027) 10.2 Insulin Like Growth Factor I Market Estimates and Projections by Application 10.2.1 Global Forecasted Sales of Insulin Like Growth Factor I by Application (2022-2027) 10.2.2 Global Forecasted Revenue of Insulin Like Growth Factor I by Application (2022-2027) 10.3 Insulin Like Growth Factor I Market Estimates and Projections by Region 10.3.1 Global Forecasted Sales of Insulin Like Growth Factor I by Region (2022-2027) 10.3.2 Global Forecasted Revenue of Insulin Like Growth Factor I by Region (2022-2027) 11 Research Finding and Conclusion 12 Methodology and Data Source 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Author List 12.4 Disclaimer

List of Tables Table 1. Global Insulin Like Growth Factor I Sales (K Pcs) Growth Rate Comparison by Type (2021-2027) Table 2. Global Insulin Like Growth Factor I Sales (K Pcs) Comparison by Application (2021-2027) Table 3. Global Insulin Like Growth Factor I Market Size by Region (US$ Million) (2016 VS 2021 VS 2027) Table 4. Key Manufacturers Insulin Like Growth Factor I Covered in This Study Table 5. Global Insulin Like Growth Factor I Sales (K Pcs) of Key Manufacturers (2016-2021) Table 6. Global Insulin Like Growth Factor I Sales Share by Manufacturers (2016-2021) Table 7. Global Insulin Like Growth Factor I Revenue (US$ Million) by Manufacturers (2016-2021) Table 8. Global Insulin Like Growth Factor I Revenue Share by Manufacturers (2016-2021) Table 9. Global Market Insulin Like Growth Factor I Average Price (USD/Pcs) of Key Manufacturers (2016-2021) Table 10. Manufacturers Insulin Like Growth Factor I Manufacturing Sites and Area Served Table 11. Manufacturers Insulin Like Growth Factor I Product Type Table 12. Global Insulin Like Growth Factor I Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global Insulin Like Growth Factor I by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Insulin Like Growth Factor I as of 2020) Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Global Insulin Like Growth Factor I Sales by Region (2016-2021) & (K Pcs) Table 16. Global Insulin Like Growth Factor I Sales Market Share by Region (2016-2021) Table 17. Global Insulin Like Growth Factor I Revenue by Region (2016-2021) & (US$ Million) Table 18. North America Insulin Like Growth Factor I Sales by Country (2016-2021) & (K Pcs) Table 19. North America Insulin Like Growth Factor I Sales Market Share by Country (2016-2021) Table 20. North America Insulin Like Growth Factor I Revenue by Country (2016-2021) & (US$ Million) Table 21. North America Insulin Like Growth Factor I Revenue Market Share by Country (2016-2021) Table 22. Europe Insulin Like Growth Factor I Sales by Country (2016-2021) & (K Pcs) Table 23. Europe Insulin Like Growth Factor I Sales Market Share by Country (2016-2021) Table 24. Europe Insulin Like Growth Factor I Revenue by Country (2016-2021) & (US$ Million) Table 25. Europe Insulin Like Growth Factor I Revenue Market Share by Country (2016-2021) Table 26. Asia Pacific Insulin Like Growth Factor I Sales by Region (2016-2021) & (K Pcs) Table 27. Asia Pacific Insulin Like Growth Factor I Sales Market Share by Region (2016-2021) Table 28. Asia Pacific Insulin Like Growth Factor I Revenue by Region (2016-2021) & (US$ Million) Table 29. Asia Pacific Insulin Like Growth Factor I Revenue Market Share by Region (2016-2021) Table 30. Latin America Insulin Like Growth Factor I Sales by Country (2016-2021) & (K Pcs) Table 31. Latin America Insulin Like Growth Factor I Sales Market Share by Country (2016-2021) Table 32. Latin America Insulin Like Growth Factor I Revenue by Country (2016-2021) & (US$ Million) Table 33. Latin America Insulin Like Growth Factor I Revenue Market Share by Country (2016-2021) Table 34. Middle East and Africa Insulin Like Growth Factor I Sales by Country (2016-2021) & (K Pcs) Table 35. Middle East and Africa Insulin Like Growth Factor I Sales Market Share by Country (2016-2021) Table 36. Middle East and Africa Insulin Like Growth Factor I Revenue by Country (2016-2021) & (US$ Million) Table 37. Middle East and Africa Insulin Like Growth Factor I Revenue Market Share by Country (2016-2021) Table 38. Global Insulin Like Growth Factor I Sales (K Pcs) by Type (2016-2021) Table 39. Global Insulin Like Growth Factor I Sales Market Share by Type (2016-2021) Table 40. Global Insulin Like Growth Factor I Revenue (Million US$) by Type (2016-2021) Table 41. Global Insulin Like Growth Factor I Revenue Share by Type (2016-2021) Table 42. Global Insulin Like Growth Factor I Price (USD/Pcs) by Type (2016-2021) Table 43. Global Insulin Like Growth Factor I Sales (K Pcs) by Application (2016-2021) Table 44. Global Insulin Like Growth Factor I Sales Market Share by Application (2016-2021) Table 45. Global Insulin Like Growth Factor I Revenue (Million US$) by Application (2016-2021) Table 46. Global Insulin Like Growth Factor I Revenue Share by Application (2016-2021) Table 47. Global Insulin Like Growth Factor I Price (USD/Pcs) by Application (2016-2021) Table 48. Boehringer Ingelheim GmbH Corporation Information Table 49. Boehringer Ingelheim GmbH Description and Business Overview Table 50. Boehringer Ingelheim GmbH Insulin Like Growth Factor I Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021) Table 51. Boehringer Ingelheim GmbH Insulin Like Growth Factor I Product Table 52. Boehringer Ingelheim GmbH Recent Developments/Updates Table 53. Genervon Biopharmaceuticals LLC Corporation Information Table 54. Genervon Biopharmaceuticals LLC Description and Business Overview Table 55. Genervon Biopharmaceuticals LLC Insulin Like Growth Factor I Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021) Table 56. Genervon Biopharmaceuticals LLC Insulin Like Growth Factor I Product Table 57. Genervon Biopharmaceuticals LLC Recent Developments/Updates Table 58. MedImmune LLC Corporation Information Table 59. MedImmune LLC Description and Business Overview Table 60. MedImmune LLC Insulin Like Growth Factor I Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021) Table 61. MedImmune LLC Insulin Like Growth Factor I Product Table 62. MedImmune LLC Recent Developments/Updates Table 63. Regulaxis SAS Corporation Information Table 64. Regulaxis SAS Description and Business Overview Table 65. Regulaxis SAS Insulin Like Growth Factor I Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021) Table 66. Regulaxis SAS Insulin Like Growth Factor I Product Table 67. Regulaxis SAS Recent Developments/Updates Table 68. Production Base and Market Concentration Rate of Raw Material Table 69. Key Suppliers of Raw Materials Table 70. Insulin Like Growth Factor I Distributors List Table 71. Insulin Like Growth Factor I Customers List Table 72. Insulin Like Growth Factor I Market Trends Table 73. Insulin Like Growth Factor I Growth Drivers Table 74. Insulin Like Growth Factor I Market Restraints Table 75. Global Insulin Like Growth Factor I Sales Forecast by Type (2022-2027) & (K Pcs) Table 76. Global Insulin Like Growth Factor I Sales Market Share Forecast by Type (2022-2027) Table 77. Global Insulin Like Growth Factor I Revenue Forecast by Type (2022-2027) & (US$ Million) Table 78. Global Insulin Like Growth Factor I Revenue Market Share Forecast by Type (2022-2027) Table 79. Global Insulin Like Growth Factor I Sales Forecast by Application (2022-2027) & (K Pcs) Table 80. Global Insulin Like Growth Factor I Sales Market Share Forecast by Application (2022-2027) Table 81. Global Insulin Like Growth Factor I Revenue Forecast by Application (2022-2027) & (US$ Million) Table 82. Global Insulin Like Growth Factor I Revenue Market Share Forecast by Application (2022-2027) Table 83. Global Insulin Like Growth Factor I Sales Forecast by Region (2022-2027) & (K Pcs) Table 84. Global Insulin Like Growth Factor I Sales Market Share Forecast by Region (2022-2027) Table 85. Global Insulin Like Growth Factor I Revenue Forecast by Region (2022-2027) & (US$ Million) Table 86. Global Insulin Like Growth Factor I Revenue Market Share Forecast by Region (2022-2027) Table 87. Research Programs/Design for This Report Table 88. Key Data Information from Secondary Sources Table 89. Key Data Information from Primary Sources List of Figures Figure 1. Product Picture of Insulin Like Growth Factor I Figure 2. Global Insulin Like Growth Factor I Market Share by Type in 2020 & 2027 Figure 3. CIGB-845 Product Picture Figure 4. Dusigitumab Product Picture Figure 5. GM-6 Product Picture Figure 6. M-610.27 Product Picture Figure 7. M-630 Product Picture Figure 8. Others Product Picture Figure 9. Global Insulin Like Growth Factor I Market Share by Application in 2020 & 2027 Figure 10. Alzheimer's Disease Figure 11. Breast Cancer Figure 12. Huntington Disease Figure 13. Muscular Dystrophy Figure 14. Others Figure 15. Global Insulin Like Growth Factor I Revenue, (US$ Million), 2016 VS 2021 VS 2027 Figure 16. Global Insulin Like Growth Factor I Market Size 2016-2027 (US$ Million) Figure 17. Global Insulin Like Growth Factor I Sales 2016-2027 (K Pcs) Figure 18. Global Insulin Like Growth Factor I Market Size Market Share by Region: 2016 VS 20210 VS 2027 Figure 19. Insulin Like Growth Factor I Sales Share by Manufacturers in 2020 Figure 20. Global Insulin Like Growth Factor I Revenue Share by Manufacturers in 2020 Figure 21. The Global 5 and 10 Largest Insulin Like Growth Factor I Players: Market Share by Revenue in 2020 Figure 22. Insulin Like Growth Factor I Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021 Figure 23. Global Insulin Like Growth Factor I Sales Market Share by Region (2016-2021) Figure 24. Global Insulin Like Growth Factor I Sales Market Share by Region in 2020 Figure 25. Global Insulin Like Growth Factor I Revenue Market Share by Region (2016-2021) Figure 26. Global Insulin Like Growth Factor I Revenue Market Share by Region in 2020 Figure 27. U.S. Insulin Like Growth Factor I Revenue Growth Rate (2016-2021) (US$ Million) Figure 28. Canada Insulin Like Growth Factor I Revenue Growth Rate (2016-2021) (US$ Million) Figure 29. Germany Insulin Like Growth Factor I Revenue Growth Rate (2016-2021) (US$ Million) Figure 30. France Insulin Like Growth Factor I Revenue Growth Rate (2016-2021) (US$ Million) Figure 31. U.K. Insulin Like Growth Factor I Revenue Growth Rate (2016-2021) (US$ Million) Figure 32. Italy Insulin Like Growth Factor I Revenue Growth Rate (2016-2021) (US$ Million) Figure 33. Russia Insulin Like Growth Factor I Revenue Growth Rate (2016-2021) (US$ Million) Figure 34. China Insulin Like Growth Factor I Revenue Growth Rate (2016-2021) (US$ Million) Figure 35. Japan Insulin Like Growth Factor I Revenue Growth Rate (2016-2021) (US$ Million) Figure 36. South Korea Insulin Like Growth Factor I Revenue Growth Rate (2016-2021) (US$ Million) Figure 37. India Insulin Like Growth Factor I Revenue Growth Rate (2016-2021) (US$ Million) Figure 38. Australia Insulin Like Growth Factor I Revenue Growth Rate (2016-2021) (US$ Million) Figure 39. Taiwan Insulin Like Growth Factor I Revenue Growth Rate (2016-2021) (US$ Million) Figure 40. Indonesia Insulin Like Growth Factor I Revenue Growth Rate (2016-2021) (US$ Million) Figure 41. Thailand Insulin Like Growth Factor I Revenue Growth Rate (2016-2021) (US$ Million) Figure 42. Malaysia Insulin Like Growth Factor I Revenue Growth Rate (2016-2021) (US$ Million) Figure 43. Philippines Insulin Like Growth Factor I Revenue Growth Rate (2016-2021) (US$ Million) Figure 44. Vietnam Insulin Like Growth Factor I Revenue Growth Rate (2016-2021) (US$ Million) Figure 45. Mexico Insulin Like Growth Factor I Revenue Growth Rate (2016-2021) (US$ Million) Figure 46. Brazil Insulin Like Growth Factor I Revenue Growth Rate (2016-2021) (US$ Million) Figure 47. Argentina Insulin Like Growth Factor I Revenue Growth Rate (2016-2021) (US$ Million) Figure 48. Turkey Insulin Like Growth Factor I Revenue Growth Rate (2016-2021) (US$ Million) Figure 49. Saudi Arabia Insulin Like Growth Factor I Revenue Growth Rate (2016-2021) (US$ Million) Figure 50. U.A.E Insulin Like Growth Factor I Revenue Growth Rate (2016-2021) (US$ Million) Figure 51. Sales Market Share of Insulin Like Growth Factor I by Type (2016-2021) Figure 52. Sales Market Share of Insulin Like Growth Factor I by Application (2016-2021) Figure 53. Sales Market Share of Insulin Like Growth Factor I by Application in 2020 Figure 54. Revenue Share of Insulin Like Growth Factor I by Application (2016-2021) Figure 55. Revenue Share of Insulin Like Growth Factor I by Application in 2020 Figure 56. Manufacturing Cost Structure of Insulin Like Growth Factor I Figure 57. Manufacturing Process Analysis of Insulin Like Growth Factor I Figure 58. Insulin Like Growth Factor I Industrial Chain Analysis Figure 59. Channels of Distribution Figure 60. Distributors Profiles Figure 61. Bottom-up and Top-down Approaches for This Report Figure 62. Data Triangulation Figure 63. Key Executives Interviewed

Boehringer Ingelheim GmbH Genervon Biopharmaceuticals LLC MedImmune LLC Regulaxis SAS